CRISPR-mediated gene editing to rescue haploinsufficient obesity syndrome.
10.1007/s13238-019-0635-y
- Author:
Zhifeng WANG
1
;
Liu YANG
2
;
Shen QU
3
;
Chao ZHANG
4
Author Information
1. Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
2. Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
3. Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200092, China. qushencn@hotmail.com.
4. Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China. zhangchao@tongji.edu.cn.
- Publication Type:Journal Article
- From:
Protein & Cell
2019;10(10):705-708
- CountryChina
- Language:English
